Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 6.

Article

Fonarow, G.C., van Hout, B. orcid.org/0000-0001-9698-6094, Villa, G. et al. (2 more authors) (2019) Updated cost-effectiveness analysis of evolocumab in patients with very high-risk atherosclerotic cardiovascular disease. JAMA Cardiology. ISSN 2380-6583

Di Tanna, G.L., Porter, J.K., Lipton, R.B. et al. (5 more authors) (2019) Migraine day frequency in migraine prevention: longitudinal modelling approaches. BMC Medical Research Methodology, 19. 20. ISSN 1471-2288

Lipton, R.B., Brennan, A. orcid.org/0000-0002-1025-312X, Palmer, S. et al. (7 more authors) (2018) Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective. Journal of Medical Economics (JME). pp. 1-10. ISSN 1369-6998

Fonarow, G.C., Keech, A.C., Pedersen, T.R. et al. (8 more authors) (2017) Cost-effectiveness of Evolocumab therapy for reducing cardiovascular events in patients with atherosclerotic cardiovascular disease. JAMA Cardiology, 2 (10). pp. 1069-1078. ISSN 2380-6583

Villa, G., Lothgren, M., Kutikova, L. et al. (7 more authors) (2017) Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain. Clinical Therapeutics, 39 (4). pp. 771-786. ISSN 0149-2918

Gandra, S.R., Villa, G., Fonarow, G.C. et al. (4 more authors) (2016) Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States. Clinical Cardiology, 39 (6). pp. 313-320. ISSN 0160-9289

This list was generated on Sun Oct 20 16:17:20 2019 BST.